1 The pressor responses produced by the intravenous administration of a,#-methylene ATP were tachyphylactic.
Introduction
Since it was first proposed that cotransmission involving adrenergic and purinergic elements may occur in some vascular smooth muscle (Sneddon & Burnstock, 1984) , further evidence for this phenomenon has been reported both in vitro (Ishikawa, 1985; von Kugelen & Starke, 1985; Cheung & Fujioka, 1986; Kennedy et al., 1986; Muramatsu, 1986; Vidal et al., 1986; Burnstock & Warland, 1987 ; Ramme et al., 1987) and in vivo .
In previous studies using the pithed rat, we demonstrated that the P21-purinoceptor desensitizing agent, a,#-methylene ATP (mATP) (Burnstock & Kennedy, 1985) could attenuate pressor responses to sympathetic nerve stimulation after blockade of a-adrenoceptors but not in the absence of ablockade Grant et al., 1985) . This seemed to suggest a relatively minor role for purinergic co-transmission in rat vasculature. We now show that by adopting a novel desensitization schedule for mATP and taking into account the short life of mATP in vivo, pressor responses due to sympathetic nerve stimulation can be shown to be more sensitive to mATP than was previously suggested. In order to verify our interpretation, we also monitored tension in the vas deferens in vivo since it is well established in vitro that this organ has adrenergic/purinergic cotransmission (Sneddon et al., 1983; Meldrum & Burnstock, 1983; Sneddon & Burnstock, 1984; Sneddon & Westfall, 1984; Stjarne & Astrand, 1984; 1985) .
A preliminary communication of these results has been published (Bulloch & McGrath, 1986) .
Methods
Male Wistar rats (250g) were pithed under halothane anaesthesia (Gillespie et al., 1970) and were artificially ventilated with 40% oxygen and 60% nitrogen and given gallamine i.v.) to stop skeletal muscle twitching and propranolol (1mgkg-', i.v.) to eliminate vasodilatation due to catecholamine release from the adrenal medulla or 'endogenous adrenaline reversal' . Drugs were administered via the right external jugular vein. Right carotid arterial blood pressure and heart rate, derived electronically from this signal, were monitored continuously: diastolic pressor responses to sympathetic nerve stimulation via the pithing rod (1 cm electrode, T8, I s, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] were measured.
%) The Macmillan Press Ltd 1988 Longitudinal tension responses of the vasa deferentia were recorded in situ by the method employed by Gillespie & McGrath (1974) to stimulation of the spinal sympathetic outflow from the pithing rod electrode (1 cm electrode, T13,i s, 5-20 Hz).
The desensitization procedure for P2-purinoceptors in vivo was as follows: An initial single bolus injection of mATP, 0.5 mgkg 1, caused heart failure in the rats. Therefore an initial low dose of mATP of 0.05mg kg1 was introduced to desensitize the heart to this effect of mATP. A final cumulative dose ofmATP ofapproximately 2.5 mg kg -1 was gradually introduced to the rat. The first 2 boluses ofmATP were given at a dose level of 0.05 mg kg -l. This was followedby5separatebolusesofmATPatadoselevelof 0.5 mg kg-1 approximately every 60 s. This desensitization procedure spanned a 7 min period.
Male New Zealand white rabbits (3-4 kg) were pithed under halothane anaesthesia (McGrath & McKenzie, 1977) The means and standard errors of the mean for the groups of experiments shown in this paper were calculated and the means were compared using the paired t test. P values of 0.05 or less were considered to be significant. n is the number of preparations.
Results
Effects ofantagonists on pressor responses to stimulation ofspinal sympathetic outflow to mATP. The first response was biphasic having an immediate transient short-lived pressor effect and a second longer lasting pressor phase. It was also accompanied by an increase in heart rate. Subsequent doses produced a monophasic pressor response equivalent to the second phase and did not alter heart rate. After desensitization the pressor responses were not significantly larger than responses to the equivalent volume of 0.9% saline.
Following completion of the desensitization schedule for mATP, attenuation of nerve-mediated pressor responses occurred in a time-dependent manner: maximum blockade occurred 1 min after the addition of mATP but faded within 10min to a maintained desensitization (Figure 2 ).
Responses to sympathetic nerve stimulation were only partially blocked by the administration of the a-adrenoceptor antagonists prazosin and rauwolscine together (each 1 mg kg 1) (Figure 3) , leaving approximately 60% of the response when stimulating the T8 region for 1 s at 20 Hz.
In the absence of a-adrenoceptor antagonists, the desensitizing doses of mATP reduced pressor responses to sympathetic nerve stimulation to approximately 40% of control levels (Figure 4) .
In the presence of a-adrenoceptor antagonists, subsequent additions of mATP which gave a final cumulative dose of 2.5 mgkg-1 completely blocked the pressor responses (Figure 3 ). Figure 4 Peak vasopressor responses to sympathetic nerve stimulation (T6-T8) for Is at 20Hz were measured as changes in diastolic blood pressure (ADBP) (in the absence of a-adrenoceptor antagonists); in control conditions (propranolol lmgkg-1 and gallamine l0mgkg-1) and after P2-purinoceptor desensitizing doses of a4i-methylene ATP (mATP).
Within 10min after the addition of mATP these same three doses of NA gave pressor responses of 22 + 6, 35 ± 8, and 60 ± 5 mmHg and were not significantly different from the control responses. The sequences of the addition of the NA doses were alternated in each experiment since the blocking effect of mATP on the nerve-mediated pressor responses is time-dependent ( Figure 5 ).
The effect of acl-methylene ATP on vas deferens responses
The longitudinal tension responses of the vas deferens produced by stimulating the spinal sympathetic outflow and the effects on these of the sequential administration of propranolol, prazosin, rauwolscine and mATP were studied. Neither propranolol (1 mgkg 1) nor prazosin (1 mg kg 1) affected the monophasic contractions of the vas deferens ( Figure 6 ).
Rauwolscine (1 mg kg-1) significantly increased the responses (Figure 6 ). The same dose schedule for mATP as in the rat produced pressor responses which exhibited tachyphylaxis but caused no detectable change in the a-blocker-resistant pressor response. The stimulation parameters were the same as those used in the rat except that longer pulse trains were employed, in a vain attempt to uncover a purinergic element. The prazosin/rauwolscine-resistant component in this case could only be slightly attenuated by additions of mATP. This might indicate that, for the resistance vessels of the vascular beds stimulated from this particular spinal level, the rabbit has a very small purinergic component in comparison to the rat, which in turn has a relatively small x-adrenergic component.
Discussion
The results suggest that the widespread sympathetic vasopressor response to stimulation of the sympathetic outflow in the rat comprises a-adrenergic and purinergic elements since it can be partly blocked by a-adrenoceptor antagonists or a purinoceptor P21 desensitizing agent but can be completely blocked by a combination.
An attempt was made to analyse any possible purinergic element in two pithed rabbits by use of a similar protocol to that for the rats. There was an a-blocker-resistant component but this was proportionally smaller than in the rat. However, despite varying the pulse number over a wide range, which might have shown up any otherwise hidden, timerelated purinergic component, we could not produce any significant blockade with mATP. Tachyphylaxis to the mATP dose schedule occurred but either this did not achieve the same degree of P21-purinoceptor desensitization as in the rat, or no nerve-mediated response via this receptor occurs with this form of stimulation in the rabbit.
On its own, mATP significantly attenuated the vasopressor responses to nerve stimulation in the pithed rat, by about 60%. After a combination of a -and OC2-adrenoceptor antagonists, the residual response was completely removed by mATP. This blocking effect of mATP was deemed to be specific against P2-purinoceptors since a similar dose of mATP had no effect on the pressor responses produced by the intravenous administration of noradrenaline. Taken together, this suggests that the response to this particular stimulus (20 pulses at 20 Hz) consists of two additive elements, 40% a-adrenergic (mainly al) and 60% purinergic.
mATP attenuates the non-adrenergic component of nerve induced contractions of the vas deferens in vitro (Sneddon & Burnstock, 1984) . We confirmed this in the pithed rat to verify the selectivity and the time course of blockade of mATP in vivo. Whereas a long-lived desensitization can be maintained in vitro, in the pithed rat a parallel rapid loss of mATP's effect was clear in both vas deferens and resistance blood vessels, making this a critical consideration when employing mATP as a blocker of putative purinergic transmission. As expected from in vitro studies (Brown et al., 1983; McGrath, 1984 ) the vas deferens 'twitch' to a short train of pulses at high frequency showed no substantial post-junctional aadrenergic component but this largely purinergic response was under a small degree of autofeedback via a2-adrenoceptors.
Previously we have shown that the direct pressor response to stimulation of the sympathetic outflow can be only partially blocked by reserpine suggesting that NA is not the only transmitter. However, transmission can be completely blocked by pretreatment with 6-hydroxydopamine (6-OHDA) suggesting that only nerves possessing uptake and accumulation sites for phenylethanolamines are involved . This was consistent with the entire response arising from adrenergic nerves but part of it (the reserpine-resistant element) not requiring NA, as would arise if there was a cotransmitter. However our earlier failure to abolish the response with a combination of mATP and aadrenoceptor antagonists left open the possibilities of another co-transmitter or of an adrenergic response that was not mediated by a-adrenoceptors. The present results show that this arose because we failed to detect the transience of the blockade with mATP. All data from the pithed rat are now consistent with the hypothesis that NA and ATP can act as co-transmitters at vascular neuroeffector junctions and produce additive responses through only aadrenoceptors and P2-purinoceptors, respectively. J.M.B. held an SERC CASE studentship in collaboration with Pfizer Central Research.
